Japan
SIMPLEX QUANTUM, Inc. is a medical technology company that has been making waves in the industry since its establishment in 2014. With the slogan "Create/implement artificial intelligence throughout global medical domains," the company is dedicated to leveraging AI to innovate medical domains with accurate and precise diagnostics.
The company is currently focused on developing an AI database using cutting-edge machine learning technologies to enable early identification of various types of cardiovascular diseases. In collaboration with the University of Tokyo Hospital, SIMPLEX QUANTUM is dedicated to researching methods to automatically detect heart failure from ECG data results. Notably, the research team has successfully developed the world's first AI algorithms for heart failure staging using only Lead-I ECG.
The company recently received a Series A investment from ITOCHU Technology Ventures on 01 November 2022, indicative of the confidence and interest that investors have in the potential of SIMPLEX QUANTUM. As the company continues to develop more applications with its proprietary SQ AI, it is poised to drive significant improvements in healthcare on a wider scale.
